Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma
about
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancersDouble-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cellsImmune targeting of cancer stem cells in gastrointestinal oncologyBiomarkers and Targeted Therapy in Pancreatic CancerTargeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI InhibitorsKey players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsAldehyde dehydrogenase 1A1 in stem cells and cancerAldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsHeterogeneity and targeting of pancreatic cancer stem cellsUnderstanding glioma stem cells: rationale, clinical relevance and therapeutic strategiesHuman correlates of provocative questions in pancreatic pathologyConcise Review: Stem Cells in Pancreatic Cancer: From Concept to Translationp-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signalingAn integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancerResveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transitionEstablishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model systemReversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cellsSnail contributes to the maintenance of stem cell-like phenotype cells in human pancreatic cancer.Cancer stem cells: a systems biology view of their role in prognosis and therapyDesign, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer.Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple OpponentsCombination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer CellsDifferential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancerTargeting Hedgehog--a cancer stem cell pathwayALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancerAldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cellsCharacterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell linesPAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis.Tumor-initiating cells are rare in many human tumorsA mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human diseaseImmunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cellsCoexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.Tackling the cancer stem cells - what challenges do they pose?Pancreatic ductal adenocarcinoma: long-term survival does not equal cureImpact of diabetes type II and chronic inflammation on pancreatic cancer.
P2860
Q21562662-8A5B5232-A133-4B5F-8B1F-E3C1C29B1A79Q24598592-788D8E62-D5AE-412E-81E2-15D298852988Q26749015-ECF15C07-8853-4A0B-A811-BF1EF8E4C910Q26752755-4AFA3AE4-04E0-45F3-91AE-6F12EF6D24B0Q26764892-C9E41C08-434B-4AC6-8D96-20B94689B03BQ26766065-C12DBD79-E1BB-4446-BC44-19C524CD4900Q26771185-44842DC7-8582-47E7-9D3B-A6FE355D27EDQ26786476-E3B79BBF-2F84-423B-879E-B7B3012AEDA0Q26851734-8A6B5182-052D-4886-82C7-E1F15E6AC1CEQ26995698-20DEB967-6F1F-42C3-A91F-4B814C39D559Q27023576-32432CE7-E21D-4A2A-8EC6-F4E5189B1FBDQ28081553-58514935-42A3-4174-B07E-C4417EA50CB7Q28269527-30ADE2F1-8877-466F-814A-55AEA5F3AA93Q28392205-6D999C4A-B687-4CE9-B4D7-117769A46BBDQ28477031-6EE092DD-1A7E-4496-9067-6A54DCBDD6E7Q28485145-026233BC-0886-4224-BF2D-095C0269C9EDQ28534611-B901D78A-CAD0-4F1B-ABE4-7AB5701F5F75Q31149299-9507E679-A47F-418B-9D1A-2B8E9C82741AQ33569712-AC077B6C-C235-454A-82BE-240D90F643BEQ33687409-5676C999-7A4D-43D8-98E8-F96A5AB2C21FQ33704284-7E2D123B-EC1E-49C3-9309-8D89BE3913FCQ33778101-7F33EA86-8F49-4C2B-9478-2F824998DD10Q33826323-B675F7E1-40B1-4909-9908-944A0E7CD228Q33864238-C1A9519F-37EE-4723-893B-53AAF5EDB54AQ33886974-D49D464D-C08B-40BA-A55B-DBC478FD34E8Q33925257-23F9604B-6265-4DFB-8974-0E65A6A9680CQ33939548-54A3BFFB-4AED-4C00-9D57-13E554AD5002Q33943803-24DC582F-7E83-490D-849E-E10D8A988522Q34026132-FF5EEF40-B3AD-4C69-9B95-CF476F9B44D7Q34043793-5394C4D5-742E-407B-84C7-6736AAEFBCFBQ34078502-9C66FE63-8B34-43B7-BBCA-B85EE5A76EA6Q34147719-D4E97C88-844C-4E15-8A86-CF709FC32CFEQ34156000-929FCC47-F8F6-4876-B707-F3897ADFA980Q34209378-7447BFDC-D488-4CBB-85DA-49F954DE2A80Q34308747-D027300F-1C7D-4797-9E43-9126E5F040B0Q34502783-2CFCA0D6-F596-429F-A6A0-E383F1EDE15BQ34511523-D43CE517-B73C-4BE0-91B6-3587E1CC9D04Q34523263-1C4D958B-475C-4012-924D-73B286EA6F5EQ34639984-82B02299-1CCB-48A5-8D13-2787D306C4ABQ34669348-DD75CC08-34AD-460D-AE09-E7D3B91AF406
P2860
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prognostic significance of tum ...... s in pancreatic adenocarcinoma
@ast
Prognostic significance of tum ...... s in pancreatic adenocarcinoma
@en
type
label
Prognostic significance of tum ...... s in pancreatic adenocarcinoma
@ast
Prognostic significance of tum ...... s in pancreatic adenocarcinoma
@en
prefLabel
Prognostic significance of tum ...... s in pancreatic adenocarcinoma
@ast
Prognostic significance of tum ...... s in pancreatic adenocarcinoma
@en
P2093
P2860
P50
P356
P1476
Prognostic significance of tum ...... s in pancreatic adenocarcinoma
@en
P2093
Antonio Jimeno
Christopher Murter
Daniel Laheru
David M Berman
Irwin Freed
Jan-Bart Koorstra
N V Rajeshkumar
Qiuju Wang
Xiaobing He
P2860
P304
P356
10.1093/JNCI/DJP535
P407
P50
P577
2010-02-17T00:00:00Z